Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

HIV-1 associated Topoisomerase IIβ kinase: a potential pharmacological target for viral replication.

Ponraj K, Prabhakar M, Rathore RS, Bommakanti A, Kondapi AK.

Curr Pharm Des. 2013;19(26):4776-86. Review.

PMID:
23260019
2.

A study of the topoisomerase II activity in HIV-1 replication using the ferrocene derivatives as probes.

Kondapi AK, Satyanarayana N, Saikrishna AD.

Arch Biochem Biophys. 2006 Jun 15;450(2):123-32.

PMID:
16712776
3.

Potent antiviral activity of topoisomerase I and II inhibitors against Kaposi's sarcoma-associated herpesvirus.

González-Molleda L, Wang Y, Yuan Y.

Antimicrob Agents Chemother. 2012 Feb;56(2):893-902. doi: 10.1128/AAC.05274-11.

5.

A biochemical analysis of topoisomerase II alpha and beta kinase activity found in HIV-1 infected cells and virus.

Kondapi AK, Padmaja G, Satyanarayana N, Mukhopadyaya R, Reitz MS.

Arch Biochem Biophys. 2005 Sep 1;441(1):41-55.

PMID:
16091284
6.

Involvement of human topoisomerase II isoforms in HIV-1 reverse transcription.

Lokeswara Balakrishna S, Satyanarayana N, Kondapi AK.

Arch Biochem Biophys. 2013 Apr 15;532(2):91-102. doi: 10.1016/j.abb.2013.01.010.

PMID:
23399433
7.

1,3-Dihydroxyacridone derivatives as inhibitors of herpes virus replication.

Akanitapichat P, Lowden CT, Bastow KF.

Antiviral Res. 2000 Feb;45(2):123-34.

PMID:
10809021
8.

Downregulation of topoisomerase IIbeta in myeloid leukemia cell lines leads to activation of apoptosis following all-trans retinoic acid-induced differentiation/growth arrest.

Chikamori K, Hill JE, Grabowski DR, Zarkhin E, Grozav AG, Vaziri SA, Wang J, Gudkov AV, Rybicki LR, Bukowski RM, Yen A, Tanimoto M, Ganapathi MK, Ganapathi R.

Leukemia. 2006 Oct;20(10):1809-18.

PMID:
16932348
9.

Human immunodeficiency virus type 1 reverse transcriptase: enhancement of activity by interaction with cellular topoisomerase I.

Takahashi H, Matsuda M, Kojima A, Sata T, Andoh T, Kurata T, Nagashima K, Hall WW.

Proc Natl Acad Sci U S A. 1995 Jun 6;92(12):5694-8.

10.

CoMFA and CoMSIA studies on HIV-1 attachment inhibitors.

Lu P, Wei X, Zhang R.

Eur J Med Chem. 2010 May;45(5):1792-8. doi: 10.1016/j.ejmech.2010.01.011.

PMID:
20149491
11.

Tyrosine 656 in topoisomerase IIβ is important for the catalytic activity of the enzyme: Identification based on artifactual +80-Da modification at this site.

Grozav AG, Willard BB, Kozuki T, Chikamori K, Micluta MA, Petrescu AJ, Kinter M, Ganapathi R, Ganapathi MK.

Proteomics. 2011 Mar;11(5):829-42. doi: 10.1002/pmic.201000194.

12.

Antiviral activity of topoisomerase II catalytic inhibitors against Epstein-Barr virus.

Wu T, Wang Y, Yuan Y.

Antiviral Res. 2014 Jul;107:95-101. doi: 10.1016/j.antiviral.2014.05.003.

PMID:
24821256
14.

Suppression of HIV-1 viral replication and cellular pathogenesis by a novel p38/JNK kinase inhibitor.

Muthumani K, Wadsworth SA, Dayes NS, Hwang DS, Choo AY, Abeysinghe HR, Siekierka JJ, Weiner DB.

AIDS. 2004 Mar 26;18(5):739-48.

PMID:
15075508
16.

Regulation of DNA Topoisomerase IIbeta through RNA-dependent association with heterogeneous nuclear ribonucleoprotein U (hnRNP U).

Kawano S, Miyaji M, Ichiyasu S, Tsutsui KM, Tsutsui K.

J Biol Chem. 2010 Aug 20;285(34):26451-60. doi: 10.1074/jbc.M110.112979.

17.

Inhibition of human immunodeficiency virus by a new class of pyridine oxide derivatives.

Stevens M, Pannecouque C, De Clercq E, Balzarini J.

Antimicrob Agents Chemother. 2003 Sep;47(9):2951-7.

18.

Topoisomerase IIα, rather than IIβ, is a promising target in development of anti-cancer drugs.

Chen W, Qiu J, Shen YM.

Drug Discov Ther. 2012 Oct;6(5):230-7. Review.

19.

Altered expression and activity of topoisomerases during all-trans retinoic acid-induced differentiation of HL-60 cells.

Aoyama M, Grabowski DR, Isaacs RJ, Krivacic KA, Rybicki LA, Bukowski RM, Ganapathi MK, Hickson ID, Ganapathi R.

Blood. 1998 Oct 15;92(8):2863-70.

20.

Inhibition of human immunodeficiency virus type 1 replication in latently infected cells by a novel IkappaB kinase inhibitor.

Victoriano AF, Asamitsu K, Hibi Y, Imai K, Barzaga NG, Okamoto T.

Antimicrob Agents Chemother. 2006 Feb;50(2):547-55.

Items per page

Supplemental Content

Support Center